Ann Lab Med.  2020 May;40(3):224-231. 10.3343/alm.2020.40.3.224.

A Novel Heterozygous Missense Variant (c.667G>T;p.Gly223Cys) in USH1C That Interferes With Cadherin-Related 23 and Harmonin Interaction Causes Autosomal Dominant Nonsyndromic Hearing Loss

• Song JS
• Bahloul A
• Petit C
• Kim SJ
• Moon IJ
• Lee J
• Ki CS

• KMID: 2466015
• DOI: http://doi.org/10.3343/alm.2020.40.3.224

Abstract

BACKGROUND
Pathogenic variants of USH1C, encoding a PDZ-domain-containing protein called harmonin, have been known to cause autosomal recessive syndromic or nonsyndromic hearing loss (NSHL). We identified a causative gene in a large Korean family with NSHL showing a typical pattern of autosomal dominant (AD) inheritance.
METHODS
Exome sequencing was performed for five affected and three unaffected individuals in this family. Following identification of a candidate gene variant, segregation analysis and functional studies, including circular dichroism and biolayer interferometry experiments, were performed.
RESULTS
A novel USH1C heterozygous missense variant (c.667G>T;p.Gly223Cys) was shown to segregate with the NSHL phenotype in this family. This variant affects an amino acid residue located in the highly conserved carboxylate-binding loop of the harmonin PDZ2 domain and is predicted to disturb the interaction with cadherin-related 23 (cdh23). The affinity of the variant PDZ2 domain for a biotinylated synthetic peptide containing the PDZ-binding motif of cdh23 was approximately 16-fold lower than that of the wild-type PDZ2 domain and that this inaccessibility of the binding site was caused by a conformational change in the variant PDZ2 domain.
CONCLUSIONS
A heterozygous variant of USH1C that interferes with the interaction between cdh23 and harmonin causes novel AD-NSHL.

Keyword

Harmonin; Nonsyndromic hearing loss; USH1C; Heterozygous variant

MeSH Terms

Binding Sites
Circular Dichroism
Exome
Hearing Loss*
Hearing*
Humans
Interferometry
Phenotype
Wills

Figure

• 

  Fig. 1 Clinical and genetic findings in a Korean family with NSHL. (A) Pedigree of a large Korean family with HL; the proband is indicated with an arrow. Individuals who participated in the molecular genetic testing are marked with an asterisk on the right. Whole exome sequencing was performed for eight individuals (shaded in yellow). The presence (+) or absence (−) of the USH1C c.667G>T variant is indicated underneath each individual. (B) Fundus autofluorescence photographs and (C) full-field electroretinogram showing normal findings. (D) Pure tone audiometry result showing moderate to moderately severe HL, with an average of 53 and 56 dB for the right and left ears, respectively. (E) Caloric test result showing normal vestibular function bilaterally. (F) Sequencing chromatograms of the c.667G>T variant of USH1C in individuals who participated in the molecular genetic testing. Nomenclature is based on RefSeq NM_005709.3, with nucleotide number +1 designating the A of the start codon ATG.Abbreviations: HL, Hearing loss; NSHL, nonsyndromic hearing loss; Lt, left; Rt, right.

• 

  Fig. 2 Functional analysis and protein modeling of harmonin. (A) The affinity of the WT PDZ2 (Kd=37.6±4.1 µM) was approximately 16-fold higher than that of PDZ2 carrying the p.Gly223Cys variant (Kd=621±88 µM). (B) Circular dichroism spectra for PDZ2 WT and the PDZ2 p.Gly223Cys variant demonstrated the global secondary structure of the WT and variant PDZ2 domain and showed that the p.Gly223Cys variant causes a conformational change. (C) The normalized elution profile of the full-length p.Gly223Cys variant protein showed a left-shifted peak compared with WT full-length harmonin, and a mixture of the full-length p.Gly223Cys variant and WT harmonin revealed a further left-shifted peak. (D) The structure of the PDZ2 domain of harmonin in a complex with the PBM of cdh23 and conformational analysis of the p.Gly223Cys variant demonstrated the interaction between the PDZ2 domain of harmonin and the PDZ-binding motif of cdh23 through the GLGF motif, a highly conserved carboxylate-binding loop in a groove between the αB and βB structural elements (left). The third glycine residue in the loop region is fully conserved and adopts a left-handed α-helical conformation. Replacement of the glycine residue with cysteine leads to a conformational change with a structural modification (right).Abbreviations: WT, wild-type; SEC, size-exclusion chromatography; PBM, PDZ-binding motif.

Reference

1. Shearer AE, Hildebrand MS, Smith RJH. Hereditary hearing loss and deafness overview. In : Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews [Internet]. Seattle, WA: 1993. Updated on July 2017. https://www.ncbi.nlm.nih.gov/books/NBK1434/.

2. Blaydon DC, Mueller RF, Hutchin TP, Leroy BP, Bhattacharya SS, Bird AC, et al. The contribution of USH1C mutations to syndromic and non-syndromic deafness in the UK. Clin Genet. 2003; 63:303–307. PMID: 12702164.

3. Ahmed ZM, Smith TN, Riazuddin S, Makishima T, Ghosh M, Bokhari S, et al. Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum Genet. 2002; 110:527–531. PMID: 12107438.

4. Ouyang XM, Xia XJ, Verpy E, Du LL, Pandya A, Petit C, et al. Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness. Hum Genet. 2002; 111:26–30. PMID: 12136232.

5. Khateb S, Zelinger L, Ben-Yosef T, Merin S, Crystal-Shalit O, Gross M, et al. Exome sequencing identifies a founder frameshift mutation in an alternative exon of USH1C as the cause of autosomal recessive retinitis pigmentosa with late-onset hearing loss. PLoS One. 2012; 7:e51566. PMID: 23251578.

6. Saihan Z, Stabej Ple Q, Robson AG, Rangesh N, Holder GE, Moore AT, et al. Mutations in the USH1C gene associated with sector retinitis pigmentosa and hearing loss. Retina. 2011; 31:1708–1716. PMID: 21487335.

7. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405–424. PMID: 25741868.

8. 1000 Genomes Project Consortium. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015; 526:68–74. PMID: 26432245.

9. Bahloul A, Pepermans E, Raynal B, Wolff N, Cordier F, England P, et al. Conformational switch of harmonin, a submembrane scaffold protein of the hair cell mechanoelectrical transduction machinery. FEBS Lett. 2017; 591:2299–2310. PMID: 28653419.

10. Kamat V, Rafique A. Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions. Anal Biochem. 2017; 536:16–31. PMID: 28802648.

11. Ahmed ZM, Frolenkov GI, Riazuddin S. Usher proteins in inner ear structure and function. Physiol Genomics. 2013; 45:987–989. PMID: 24022220.

12. Wu L, Pan L, Zhang C, Zhang M. Large protein assemblies formed by multivalent interactions between cadherin23 and harmonin suggest a stable anchorage structure at the tip link of stereocilia. J Biol Chem. 2012; 287:33460–33471. PMID: 22879593.

13. Cosgrove D, Zallocchi M. Usher protein functions in hair cells and photoreceptors. Int J Biochem Cell Biol. 2014; 46:80–89. PMID: 24239741.

14. Reiners J, Wolfrum U. Molecular analysis of the supramolecular usher protein complex in the retina. Harmonin as the key protein of the Usher syndrome. Adv Exp Med Biol. 2006; 572:349–353. PMID: 17249595.

15. Kalyoncu S, Keskin O, Gursoy A. Interaction prediction and classification of PDZ domains. BMC Bioinformatics. 2010; 11:357. PMID: 20591147.

16. Siemens J, Kazmierczak P, Reynolds A, Sticker M, Littlewood-Evans A, Müller U. The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions. Proc Natl Acad Sci U S A. 2002; 99:14946–14951. PMID: 12407180.

17. Lee HJ, Zheng JJ. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal. 2010; 8:8. PMID: 20509869.